VKTX
Price:
$30.38
Market Cap:
$3.53B
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non...[Read more]
Industry
Biotechnology
IPO Date
2015-04-28
Stock Exchange
NASDAQ
Ticker
VKTX
According to Viking Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Viking Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), VKTX's Dividend Yield was at its highest in in the June 2016 quarter at 0%. The Dividend Yield was at its lowest in in the June 2016 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Viking Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
The current Dividend Yield of Viking Therapeutics, Inc. (VKTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Viking Therapeutics, Inc.’s Dividend Yield is less than Crinetics Pharmaceuticals, Inc. (0%), less than Kymera Therapeutics, Inc. (0%), less than Immunovant, Inc. (0%), less than NewAmsterdam Pharma Company N.V. (0%), less than Praxis Precision Medicines, Inc. (0%), less than Akero Therapeutics, Inc. (0%), less than Soleno Therapeutics, Inc. (0%), less than Ascentage Pharma Group International (0%), less than ACADIA Pharmaceuticals Inc. (0%), less than Ligand Pharmaceuticals Incorporated (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $3.78B | |
| 0% | $7.44B | |
| 0% | $7.26B | |
| 0% | $3.49B | |
| 0% | $5.97B | |
| 0% | $4.50B | |
| 0% | $2.76B | |
| 0% | $1.59B | |
| 0% | $3.70B | |
| 0% | $5.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Viking Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Viking Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Viking Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Viking Therapeutics, Inc. (VKTX)?
What is the highest Dividend Yield for Viking Therapeutics, Inc. (VKTX)?
What is the 3-year average Dividend Yield for Viking Therapeutics, Inc. (VKTX)?
What is the 5-year average Dividend Yield for Viking Therapeutics, Inc. (VKTX)?
How does the current Dividend Yield for Viking Therapeutics, Inc. (VKTX) compare to its historical average?